Fibrosing ILD Biomarkers That Rule Acceleration
Conditions: Pulmonary Fibrosis; Sarcoidosis Intervention: Other: Comprehensive clinical assessment and biological samples collection Sponsors: Universidade do Porto; Faculdade de Medicina da Universidade do Porto (FMUP); Centro Hospitalar De São João, E.P.E.; Instituto de Investigação e Inovação em Saúde (i3S) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2022 Category: Research Source Type: clinical trials
Fibrosing ILD Biomarkers That Rule Acceleration
Conditions: Pulmonary Fibrosis; Sarcoidosis Intervention: Other: Comprehensive clinical assessment and biological samples collection Sponsors: Universidade do Porto; Centro Hospitalar De São João, E.P.E.; Instituto de Investigação e Inovação em Saúde (i3S) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2022 Category: Research Source Type: clinical trials
Fibrosing ILD Biomarkers That Rule Acceleration
Conditions: Pulmonary Fibrosis; Sarcoidosis Intervention: Other: Comprehensive clinical assessment and biological samples collection Sponsors: Universidade do Porto; Centro Hospitalar De São João, E.P.E. (CHUSJ); Instituto de Investigação e Inovação em Saúde (i3S) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2022 Category: Research Source Type: clinical trials